carvedilol has been researched along with celiprolol in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Rahn, KH | 2 |
| De Cree, J; Geukens, H; Van Nueten, L; Verhaegen, H | 1 |
| Sponer, G; Strein, K | 1 |
| Lefflerová, K; Widimský, J | 1 |
| Belz, GG; Breithaupt-Grögler, K; De Mey, C; Palm, D; Schloos, J | 1 |
| Cleophas, TJ; van de Luit, L; van der Meulen, J; Zwinderman, AH | 1 |
| Arapogianni, AN; Aznaouridis, KA; Cokkinos, DV; Karpanou, EA; Marinakis, AG; Stefanadis, CI; Vyssoulis, GP | 1 |
4 review(s) available for carvedilol and celiprolol
| Article | Year |
|---|---|
Clinical experience with dual-acting drugs in hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Propanolamines; Vasodilator Agents | 1992 |
Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Celiprolol; Coronary Disease; Heart Failure; Hemodynamics; Humans; Labetalol; Propanolamines; Vasodilator Agents; Ventricular Function, Left | 1990 |
Antihypertensive compounds with combined actions.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Propanolamines | 1987 |
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
3 trial(s) available for carvedilol and celiprolol
| Article | Year |
|---|---|
Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Celiprolol; Electrocardiography; Ethanolamines; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nebivolol; Propanolamines; Ventricular Function, Left | 1992 |
Reproducibility and consistency of the responses to supine bicycle ergometry; evaluation in conjunction with beta 1-adrenoceptor occupancies.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Celiprolol; Epinephrine; Exercise Test; Heart Rate; Humans; Male; Metoprolol; Norepinephrine; Propanolamines; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta; Reproducibility of Results | 1994 |
Daytime-selective antihypertensive activity of celiprolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Cardiac Output, Low; Carvedilol; Celiprolol; Cerebrovascular Circulation; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Heart Rate; Humans; Hypertension; Hypotension; Male; Middle Aged; Placebos; Propanolamines; Sympathetic Nervous System | 1999 |
3 other study(ies) available for carvedilol and celiprolol
| Article | Year |
|---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzopyrans; Biomarkers; Blood Pressure; Carbazoles; Carvedilol; Celiprolol; Endothelium, Vascular; Ethanolamines; Female; Fibrinogen; Homocystine; Humans; Hypertension; Male; Middle Aged; Nebivolol; Plasminogen Activator Inhibitor 1; Propanolamines; Smoking; Treatment Outcome; Vasodilation | 2004 |